Inside Immunai: Can artificial intelligence map our immune system? Podcast Por  arte de portada

Inside Immunai: Can artificial intelligence map our immune system?

Inside Immunai: Can artificial intelligence map our immune system?

Escúchala gratis

Ver detalles del espectáculo
This week, host Eve Young, economics correspondent for The Jerusalem Post, interviews Noam Solomon - CEO and co-founder at Immunai.

Immunai is a biotechnology company working to comprehensively map and decode the immune system with single-cell biology and AI to make new therapeutic discoveries, accelerate drug development, and improve patient outcomes.

Noam will talk about how Immunai uses AI and machine learning to make medical advancements, and explain what machine learning is in laymans terms. He will also explain what kind of team is best suited to face the challenges of a complex, deep science problem like mapping human immunity.
Todavía no hay opiniones